Physician profile
Khaula Khalid
NPI 1164698445
$2,130.34
in general payments reported to CMS, 2019-2025
17 companies · $72.72 in 2025
The $72.72 reported for 2025 was less than what a typical Cardiovascular Disease provider received nationally (typical 2025 total: $433).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $528 · 2020: $71.82 · 2021: $625 · 2022: $389 · 2023: $219 · 2024: $225 · 2025: $72.72.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $517.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $516.61 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $477.90 | 2019-2021 | |
| Amgen INC. | $333.28 | 2020-2024 | Repatha |
| Merck Sharp & Dohme LLC | $257.69 | 2021-2025 | Verquvo |
| Novo Nordisk INC | $232.84 | 2019-2023 | |
| Astrazeneca Pharmaceuticals LP | $219.66 | 2021-2024 | Farxiga |
| Novartis Pharmaceuticals Corporation | $215.55 | 2020-2023 | |
| Lilly USA, LLC | $174.47 | 2022-2024 | Mounjaro |
| Glaxosmithkline, LLC. | $61.04 | 2019 | |
| Pfizer INC. | $26.67 | 2020-2021 | |
| Heartflow, INC. | $22.92 | 2025 | |
| Boston Scientific Corporation | $17.79 | 2024 | Varithena Administration Pack |
| E.R. Squibb & Sons, L.L.C. | $16.99 | 2025 | Camzyos |
| Boehringer Ingelheim Pharmaceuticals, INC. | $15.60 | 2022 | |
| Teva Pharmaceuticals USA, INC. | $14.94 | 2021 | |
| Aurinia Pharma U.S., INC. | $14.91 | 2023 | Lupkynis |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Pharmaceuticals, INC | $14.49 | 2022 | |
| Medtronic, INC. | $13.60 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Khaula Khalid listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.